(Q51520423)

English

More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome.

scientific article published in January 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Tetsuro Kusaba

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Yusuke Konno

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Shigeo Hatta

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Tomoya Fujino

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Takashi Yasuda

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Hiroshi Miura

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Hiroyo Sasaki

7

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Jun Okabayashi

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Mei Murao

9

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Tsutomu Sakurada

10

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Goro Imai

11

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Sayuri Shirai

12

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Shingo Kuboshima

13

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Yoshinori Shima

14

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Goichi Ogimoto

15

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Takeo Sato

16

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Keisou Masuhara

17

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Kenjiro Kimura

18

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

25

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

52-58

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

The effect of food and bile acid administration on the relative bioavailability of cyclosporin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.52.55617

21 January 2018

Identifiers

10.1592/PHCO.25.1.52.55617

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/15767220

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51520423&oldid=2144609176"